Insider Trading Alert - GEVO, LNG And NVAX Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, June 22, 2015, 60 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $256.20 to $3,091,980.00.

Highlighted Stocks Traded by Insiders:

Gevo (GEVO) - FREE Research Report

Gruber Patrick R., who is Chief Executive Officer at Gevo, sold 162 shares at $3.66 on June 22, 2015. Following this transaction, the Chief Executive Officer owned 18,563 shares meaning that the stake was reduced by 0.87% with the 162-share transaction.

Ryan Christopher Michael, who is President and COO at Gevo, sold 70 shares at $3.66 on June 22, 2015. Following this transaction, the President and COO owned 20,807 shares meaning that the stake was reduced by 0.34% with the 70-share transaction.

The shares most recently traded at $2.78, down $0.88, or 31.65% since the insider transaction. Historical insider transactions for Gevo go as follows:

  • 4-Week # shares bought: 181,484
  • 4-Week # shares sold: 943
  • 12-Week # shares bought: 181,484
  • 12-Week # shares sold: 13,498
  • 24-Week # shares bought: 181,484
  • 24-Week # shares sold: 70,790

The average volume for Gevo has been 326,100 shares per day over the past 30 days. Gevo has a market cap of $23.6 million and is part of the basic materials sector and chemicals industry. Shares are down 58.12% year-to-date as of the close of trading on Tuesday.

Gevo, Inc., a renewable chemicals and biofuels company, focuses on the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The company operates in two segments, Gevo, Inc.; and Gevo Development/Agri-Energy.

Exclusive Offer: Get the latest Stock Analysis on GEVO - FREE

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Cheniere Energy (LNG) - FREE Research Report

Rayford Greg W., who is Sr. VP and General Counsel at Cheniere Energy, sold 14,169 shares at $70.58 on June 22, 2015. Following this transaction, the Sr. VP and General Counsel owned 593,150 shares meaning that the stake was reduced by 2.33% with the 14,169-share transaction.

The shares most recently traded at $70.61, up $0.03, or 0.04% since the insider transaction. Historical insider transactions for Cheniere Energy go as follows:

  • 4-Week # shares sold: 162,000
  • 12-Week # shares sold: 496,000
  • 24-Week # shares sold: 1.1 million

The average volume for Cheniere Energy has been 2.2 million shares per day over the past 30 days. Cheniere Energy has a market cap of $16.6 billion and is part of the basic materials sector and energy industry. Shares are up 0.14% year-to-date as of the close of trading on Monday.

Cheniere Energy, Inc., an energy company, engages in the liquefied natural gas (LNG) related business. It operates through two segments, LNG Terminal Business, and LNG and Natural Gas Marketing Business. Currently, there are 4 analysts who rate Cheniere Energy a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LNG - FREE

TheStreet Quant Ratings rates Cheniere Energy as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income and feeble growth in its earnings per share. Get the full Cheniere Energy Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Novavax (NVAX) - FREE Research Report

Young James F, who is Director at Novavax, sold 50,000 shares at $9.47 on June 22, 2015. Following this transaction, the Director owned 375,000 shares meaning that the stake was reduced by 11.76% with the 50,000-share transaction.

The shares most recently traded at $10.70, up $1.23, or 11.47% since the insider transaction. Historical insider transactions for Novavax go as follows:

  • 4-Week # shares bought: 46,235
  • 4-Week # shares sold: 30,000
  • 12-Week # shares bought: 46,235
  • 12-Week # shares sold: 30,000
  • 24-Week # shares bought: 46,235
  • 24-Week # shares sold: 30,000

The average volume for Novavax has been 3.6 million shares per day over the past 30 days. Novavax has a market cap of $2.5 billion and is part of the health care sector and drugs industry. Shares are up 58.18% year-to-date as of the close of trading on Monday.

Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Currently, there are 6 analysts who rate Novavax a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NVAX - FREE

TheStreet Quant Ratings rates Novavax as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income and weak operating cash flow. Get the full Novavax Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

3 Things Investors Must Know for Monday

3 Things Investors Must Know for Monday

Street Stats: The Mid-Term Elections May Be a Rollercoaster Ride for Investors

Street Stats: The Mid-Term Elections May Be a Rollercoaster Ride for Investors

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric